Conference abstract · 22 Jun 2021
Conference abstractPublished 28 Aug 2017
Optimizing early phase development of amorphous solid dispersion formulation thorough application of modeling tools
AbbVie Deutschland GmbH & Co. KG, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Amorphous Solid Dispersion (ASD) is an established formulation technique for improving the bioavailability of poorly water-soluble Active Pharmaceutical Ingredients (APIs) by increasing solubility, wettability and dissolution rate. Successful manufacturing of ASD formulation by Hot Melt Extrusion (HME) requires selection of e.g. the right API load, excipients, and processing temperature. API load is also crucial in determining important quality attributes of the drug product such as long term physical stability to ensure consistent product performance during its self-life. Identifying the possible maximum drug load limit and excipients for HME feasibility and risk assessment, and long-term physical stability of the manufactured ASD can be quite challenging whereby several extrusion trials are required in addition to prolonged stability studies. Exploring the optimal design space during early phase of formulation development by this approach requires significant amount of resources including API which may be limitedly available during this phase. Methodology & Theoretical Orientation: As an API-sparing approach, novel empirical model and the rigorous thermodynamic Perturbed Chain Statistically Associating Fluid Theory (PC-SAFT) were applied to model ASD phase diagram of several formulations to effectively and quickly explore the design space to optimize formulation development. These were followed up with HME manufacturing and long-term stability studies (up to 18 months) of the formulations under ICH conditions to verify the model-predicted results. Several APIs and polymeric excipients including Soluplus, Copovidone, PVP, and HPMCAS were used in the studies. Findings: The modeling tools were found to be very suitable in estimating extrusion temperature required for generating crystal-free ASD formulations as well as predicting their physical stability under different storage conditions, i.e., temperature and relative humidity. Conclusion & Significance: Recent advances in predictive ASD phase diagram modeling proved to be reliable tools for excipient selection, HME temperature prediction, and designing ASD formulations for maximum drug load and physical stability. Applying these tools enables successful ASD formulation optimization using less resources and materials.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Apr 2021
Optimizing early phase development of amorphous solid dispersion formulation thorough application of modeling tool
Short communication · 2021
Optimizing early phase development of amorphous solid dispersion formulations thorough application of modeling tools
Conference abstract · 2021
Optimizing of amorphous solid dispersion formulation by early phase development thorough application of modeling tool
Conference abstract
Characterization of phase separation and re-crystallization of amorphous solid dispersions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectMathematics & Statistics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Samuel Kyeremateng”
